DRAK2-SRSF6-regulated RNA alternative splicing is a promising therapeutic target in NAFLD/NASH

Detalles Bibliográficos
Autores principales: Dalamaga, Maria, Liu, Junli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Articles from the NAFLD: from Molecular Basis to Therapeutic Advances Special Issue
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669361/
https://www.ncbi.nlm.nih.gov/pubmed/34917919
http://dx.doi.org/10.1016/j.metop.2021.100157

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669361/
https://www.ncbi.nlm.nih.gov/pubmed/34917919
http://dx.doi.org/10.1016/j.metop.2021.100157

Ejemplares similares